All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Referral
Contact us about this page
Dementia: Investigations and Monitoring
Scope
These recommendations are based on NICE guidance and are consistent with the requirements for quality and outcomes framework (QOF).
At diagnosis (between 12 months before and 6 months after diagnosis)
- Blood: FBC, Renal, LFTs, Calcium, HbA1C or glucose, TSH, B12 and folate.
- Follow up: no routine tests recommended
Out of scope
Testing for syphilis serology or HIV should not be routinely undertaken in the investigation of people with suspected dementia. These tests should be considered only in those with histories suggesting they are at risk or if the clinical picture dictates.
At diagnosis (between 12 months before and 6 months after diagnosis)
- Blood: FBC, Renal, LFTs, Calcium, HbA1C or glucose, TSH, B12 and folate.
- Follow up: no routine tests recommended
Testing for syphilis serology or HIV should not be routinely undertaken in the investigation of people with suspected dementia. These tests should be considered only in those with histories suggesting they are at risk or if the clinical picture dictates.
Evidence
2015/16 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF). Guidance for GMS contract 2015/16. Published: March 2015.
Pathway Group
This guideline has been signed off by Pathology Optimisation Clinical Group on behalf of NHS Devon.
Publication date: April 2017
